Restoring Breath: Biologic Innovation for the Most Vulenerable Patients
Airway Therapeutics is taking on one of the toughest challenges in medicine - helping premature infants breathe on their own. In this episode of Rx for Biotech, CEO Marc Salzberg shares how zelpultide alfa, an investigational, first-in-class biologic, could transform care for newborns with bronchopulmonary dysplasia (BPD) and unlock a new future for respiratory medicine.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.